[HTML][HTML] Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
P Zhang, Y Gu, H Fang, Y Cao, J Wang… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background With the essential role of interleukin-1 signaling in cancer-related inflammation,
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer.
P Zhang, Y Gu, H Fang, Y Cao, J Wang… - … for Immunotherapy of …, 2022 - europepmc.org
Background With the essential role of interleukin-1 signaling in cancer-related inflammation,
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
P Zhang, Y Gu, H Fang, Y Cao… - Journal for …, 2022 - pubmed.ncbi.nlm.nih.gov
Background With the essential role of interleukin-1 signaling in cancer-related inflammation,
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
[HTML][HTML] Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
P Zhang, Y Gu, H Fang, Y Cao, J Wang, H Liu… - … for ImmunoTherapy of …, 2022 - jitc.bmj.com
Background With the essential role of interleukin-1 signaling in cancer-related inflammation,
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
P Zhang, Y Gu, H Fang, Y Cao, J Wang… - Journal for …, 2022 - search.proquest.com
Background With the essential role of interleukin-1 signaling in cancer-related inflammation,
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer.
P Zhang, Y Gu, H Fang, Y Cao, J Wang… - … for Immunotherapy of …, 2022 - europepmc.org
Background With the essential role of interleukin-1 signaling in cancer-related inflammation,
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …
IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in …